171 related articles for article (PubMed ID: 2426474)
1. Carcinoembryonic antigen and beta-human chorionic gonadotropin as serum markers for advanced urothelial malignancies.
Dexeus F; Logothetis C; Hossan E; Samuels ML
J Urol; 1986 Aug; 136(2):403-7. PubMed ID: 2426474
[TBL] [Abstract][Full Text] [Related]
2. The significance of measurement of human placental lactogen, human chorionic gonadotropin, and carcinoembryonic antigen in patients with ovarian carcinoma.
Samaan NA; Smith JP; Rutledge FN; Schultz PN
Am J Obstet Gynecol; 1976 Sep; 126(2):186-9. PubMed ID: 183504
[TBL] [Abstract][Full Text] [Related]
3. Treatment of bladder carcinoma using a germ cell chemotherapy protocol.
Williams G; Colbeck RA; Crawford SM
Br J Urol; 1990 May; 65(5):473-7. PubMed ID: 1693865
[TBL] [Abstract][Full Text] [Related]
4. Carcinoembryonic antigen and bladder carcinoma.
Ionescu G; Romas NA; Ionascu L; Bennett S; Tannenbaum M; Veeneman RJ; Lattimer JK
J Urol; 1976 Jan; 115(1):46-8. PubMed ID: 1107601
[TBL] [Abstract][Full Text] [Related]
5. [Biologic behavior of human chorionic gonadotropin hormone (HCGH) in transitional cell carcinomas of the bladder].
Moreno Sierra J; Gómez Ruiz JJ; Rodríguez Molina J; Blanco Jiménez E; Silmi Moyano A; Corral Rosillo J; Ortega Heredia D; Maestro de las Casas ML; Resel Estévez L
Arch Esp Urol; 1993; 46(6):469-72. PubMed ID: 7691043
[TBL] [Abstract][Full Text] [Related]
6. Trophoblastic metaplasia in urothelial carcinoma of the bladder.
Burry AF; Munn SR; Arnold EP; McRae CU
Br J Urol; 1986 Apr; 58(2):143-6. PubMed ID: 2421816
[TBL] [Abstract][Full Text] [Related]
7. Serum and urinary levels of beta human chorionic gonadotrophin in patients with transitional cell carcinoma.
McLoughlin J; Pepera T; Bridger J; Williams G
Br J Cancer; 1991 May; 63(5):822-4. PubMed ID: 1710137
[TBL] [Abstract][Full Text] [Related]
8. High frequency of incomplete human chorionic gonadotropin in patients with testicular seminoma.
Paus E; Fosså A; Fosså SD; Nustad K
J Urol; 1988 Mar; 139(3):542-4. PubMed ID: 2449547
[TBL] [Abstract][Full Text] [Related]
9. Carcinoembryonic antigen, alphafetoprotein and alpha and beta subunits of human chorionic gonadotropin in plasma of children with acute leukaemia.
Wysocki M; Domaniewski J; Balcar-Boroń A; Cetnarowski L; Czerwionka-Szaflarska M; Sujkowska R
Acta Paediatr Hung; 1987; 28(2):119-25. PubMed ID: 2447919
[TBL] [Abstract][Full Text] [Related]
10. Beta human chorionic gonadotrophin in serum and urine. A marker for metastatic urothelial cancer.
Iles RK; Jenkins BJ; Oliver RT; Blandy JP; Chard T
Br J Urol; 1989 Sep; 64(3):241-4. PubMed ID: 2478247
[TBL] [Abstract][Full Text] [Related]
11. Human chorionic gonadotropin and CA 15-3 producing adenocarcinoma.
Uçkaya G; Ozet A; Arpaci A; Kömürcü S
Nuklearmedizin; 1998; 37(8):297-8. PubMed ID: 9868713
[TBL] [Abstract][Full Text] [Related]
12. Beta-human chorionic gonadotrophin and carcino-embryonic antigen in the management of ovarian carcinoma.
Stone M; Bagshawe KD; Kardana A; Searle F; Dent J
Br J Obstet Gynaecol; 1977 May; 84(5):375-9. PubMed ID: 889730
[TBL] [Abstract][Full Text] [Related]
13. Assessment of urinary beta-core fragment of human chorionic gonadotropin as a new tumor marker of lung cancer.
Yoshimura M; Nishimura R; Murotani A; Miyamoto Y; Nakagawa T; Hasegawa K; Koizumi T; Shii K; Baba S; Tsubota N
Cancer; 1994 Jun; 73(11):2745-52. PubMed ID: 7514953
[TBL] [Abstract][Full Text] [Related]
14. Cancer antigen 125, tissue polypeptide antigen, carcinoembryonic antigen, and beta-chain human chorionic gonadotropin as serum markers of epithelial ovarian carcinoma.
Panza N; Pacilio G; Campanella L; Peluso G; Battista C; Amoriello A; Utech W; Vacca C; Lombardi G
Cancer; 1988 Jan; 61(1):76-83. PubMed ID: 2446734
[TBL] [Abstract][Full Text] [Related]
15. Gynecomastia and ectopic human chorionic gonadotropin production by transitional cell carcinoma of the bladder.
Nishiyama T; Washiyama K; Tanikawa T; Mineyama H; Sasagawa T; Susuki H; Kitamura Y; Sato S
Urol Int; 1992; 48(4):463-5. PubMed ID: 1413316
[TBL] [Abstract][Full Text] [Related]
16. The utility of tumour markers in assessing the response to chemotherapy in advanced bladder cancer.
Cook AM; Huddart RA; Jay G; Norman A; Dearnaley DP; Horwich A
Br J Cancer; 2000 Jun; 82(12):1952-7. PubMed ID: 10864203
[TBL] [Abstract][Full Text] [Related]
17. Ectopic human chorionic gonadotrophin (HCG) production: is the detection by serum analysis of HCG of clinical relevance in transitional cell carcinoma of the bladder?
Smith DJ; Evans HJ; Newman J; Chapple CR
Br J Urol; 1994 Apr; 73(4):409-12. PubMed ID: 8199829
[TBL] [Abstract][Full Text] [Related]
18. Tumor markers in urology.
Grossman HB
Semin Urol; 1985 Feb; 3(1):10-7. PubMed ID: 2408306
[No Abstract] [Full Text] [Related]
19. Serum biomarkers in metastatic renal cell carcinoma.
Dexeus FH; Logothetis CJ; Sella A; Fitz K; Striegel A; Amato RJ; Liu FJ
Urology; 1991 Jul; 38(1):6-10. PubMed ID: 1714107
[TBL] [Abstract][Full Text] [Related]
20. Free human chorionic gonadotropin beta subunit in gonadal and nongonadal neoplasms.
Marcillac I; Troalen F; Bidart JM; Ghillani P; Ribrag V; Escudier B; Malassagne B; Droz JP; Lhommé C; Rougier P
Cancer Res; 1992 Jul; 52(14):3901-7. PubMed ID: 1377600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
